The activation of RalGDS can be achieved independently of its Ras binding domain - Implications of an activation mechanism in Ras effector specificity and signal distribution

被引:37
作者
Linnemann, T [1 ]
Kiel, C [1 ]
Herter, P [1 ]
Herrmann, C [1 ]
机构
[1] Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany
关键词
D O I
10.1074/jbc.M110800200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small GTPases of the Ras family are major players of signal transduction in eukaryotic cells. They receive signals from a number of receptors and transmit them to a variety of effectors. The distribution of signals to different effector molecules allows for the generation of opposing effects like proliferation and differentiation. To understand the specificity of Ras signaling, we investigated the activation of RalGDS, one of the Ras effector proteins with guanine-nucleotide exchange factor activity for Ral. We determined the GTP level on RalA and showed that the highly conserved Ras binding domain (RBD) of RalGDS, which mediates association with Ras, is important but not sufficient to explain the stimulation of the exchange factor. Although a point mutation in the RBD of RalGDS, which abrogates binding to Ras, renders RalGDS independent to activated Ras, an artificially membrane-targeted version of RalGDS lacking its RBD could still be activated by Ras. The switch II region of Ras is involved in the activation, because the mutant Y64W in this region is impaired in the RalGDS activation. Furthermore, it is shown that Rap1, which was originally identified as a Ras antagonist, can block Ras-mediated RalGDS signaling only when RalGDS contains an intact RBD. In addition, kinetic studies of the complex formation between RalGDS-RBD and Ras suggest that the fast association between RalGDS and Ras, which is analogous to the Ras/Raf case, achieves signaling specificity. Conversely, the Ras.RalGDS complex has a short lifetime of 0.1 s and Rap1 forms a long-lived complex with RalGDS, possibly explaining its antagonistic effect on Ras.
引用
收藏
页码:7831 / 7837
页数:7
相关论文
共 55 条
[1]   CHARACTERIZATION OF A GUANINE-NUCLEOTIDE DISSOCIATION STIMULATOR FOR A RAS-RELATED GTPASE [J].
ALBRIGHT, CF ;
GIDDINGS, BW ;
LIU, J ;
VITO, M ;
WEINBERG, RA .
EMBO JOURNAL, 1993, 12 (01) :339-347
[2]   ASSOCIATION OF THE RAS-ANTAGONISTIC RAP1/KREV-1 PROTEINS WITH THE GOLGI-COMPLEX [J].
BERANGER, F ;
GOUD, B ;
TAVITIAN, A ;
DEGUNZBURG, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (05) :1606-1610
[3]   ULTRASTRUCTURAL-LOCALIZATION OF THE SMALL GTP-BINDING PROTEIN RAP1 IN HUMAN PLATELETS AND MEGAKARYOCYTES [J].
BERGER, G ;
QUARCK, R ;
TENZA, D ;
LEVYTOLEDANO, S ;
DEGUNZBURG, J ;
CRAMER, EM .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) :372-382
[4]   Rap1 signalling: Adhering to new models [J].
Bos, JL ;
de Rooij, J ;
Reedquist, KA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (05) :369-377
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   PARTIAL GROWTH SUPPRESSION OF HUMAN PROSTATE-CANCER CELLS BY THE KREV-1 SUPPRESSOR GENE [J].
BURNEY, TL ;
ROCKOVE, S ;
EISEMAN, JL ;
JACOBS, SC ;
KYPRIANOU, N .
PROSTATE, 1994, 25 (04) :177-188
[7]   PARTIAL SUPPRESSION OF TUMORIGENICITY IN A HUMAN LUNG-CANCER CELL-LINE TRANSFECTED WITH KREV-1 [J].
CAAMANO, J ;
DIRADO, M ;
IIZASA, T ;
MOMIKI, S ;
FERNANDES, E ;
ASHENDEL, C ;
NODA, M ;
KLEINSZANTO, AJP .
MOLECULAR CARCINOGENESIS, 1992, 6 (04) :252-259
[8]   YEAST BUD5, ENCODING A PUTATIVE GDP-GTP EXCHANGE FACTOR, IS NECESSARY FOR BUD SITE SELECTION AND INTERACTS WITH BUD FORMATION GENE BEM1 [J].
CHANT, J ;
CORRADO, K ;
PRINGLE, JR ;
HERSKOWITZ, I .
CELL, 1991, 65 (07) :1213-1224
[9]   Regulation of Sos activity by intramolecular interactions [J].
Corbalan-Garcia, S ;
Margarit, SM ;
Galron, D ;
Yang, SS ;
Bar-Sagi, D .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) :880-886
[10]   rsc: A novel oncogene with structural and functional homology with the gene family of exchange factors for Ral [J].
DAdamo, DR ;
Novick, S ;
Kahn, JM ;
Leonardi, P ;
Pellicer, A .
ONCOGENE, 1997, 14 (11) :1295-1305